HOME >> BIOLOGY >> NEWS
Study provides new details of 'the birth of a virus'

e cell (see accompanying illustration). Thousands of newborn viruses now cling to the outside of the membrane, waiting for one final step to cut them loose and send them on their way to other cells.

Ten years ago, Gttlinger and his colleagues at Dana-Farber discovered that a strain of HIV that lacks the late domain was unable to break free of the membrane - remaining attached and posing no threat to the rest of the body. The new study fills in some of the gaps in scientists' understanding of how the late domain functions and how it serves as a passport through the cell's skin.

Small as the late domain is within Gag, the domain's essential core - the part that enables it to function - often consists of only a handful of molecules, primarily amino acids known as prolines. Researchers have found that all retroviruses, not just HIV, have late domains, as do a variety of other viruses.

"These findings suggest that many viruses use the same or similar mechanisms to cut themselves loose from the cell membrane," Gttlinger says. "The discovery of the proline-rich sections of the late domain enabled us to focus on precisely these areas in studying how the domain functions." The researchers hypothesized that the late domain serves as a target for cell proteins that help the virus break free from the cell membrane. Their research shows this to be precisely the case.

The possibility of interrupting the budding process marks the significance of this recently published research. Working independently, scientists at Dana-Farber Cancer Institute, Penn State's College of Medicine and The National Institute of Allergies and Infectious Diseases (NIAID) of the National Institutes of Health, published complementary papers on the role of the cellular ubiquitination machinery in late steps of retrovirus budding.

The data show the functional connection between ubiquitin and Gag (Penn State), the recruitment of ubiquitin ligase, which encourages the
'"/>

Contact: Todd Ringler
todd_ringler@dfci.harvard.edu
617-632-5357
Dana-Farber Cancer Institute
20-Nov-2000


Page: 1 2 3

Related biology news :

1. Study: Emission of smog ingredients from trees is increasing rapidly
2. Study explores gene transfer to modify underlying course of Alzheimers disease
3. Study reveals why eyes in some paintings seem to follow viewers
4. Study by Israeli scientists provides insight on DNA code
5. Study reveals first genetic step necessary for prostate cancer growth
6. Study of flu patients reveals virus outsmarting key drug
7. Study in Science reveals recreational fishing takes big bite of ocean catch
8. Study suggests cell-cycle triggers might be cancer drug targets
9. Study narrows search for genes placing men at increased risk for prostate cancer
10. Study links high carbohydrate diet to increased breast cancer risk
11. Study explains spatial orientation differences between sexes

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/8/2017)... NEW YORK , Feb. 7, 2017 /PRNewswire/ ... point. Driven largely by the confluence of organizations, ... users, distaste for knowledge-based systems (password and challenge ... consumer, industrial, and government systems. The market is ... been a demarcation between consumer and enterprise uses ...
(Date:2/6/2017)... , Feb. 6, 2017 According ... security are driving border authorities to continue to ... reports there are 2143 Automated Border Control (ABC) ... currently deployed at more than 163 ports of ... 2013 to 2016 achieving a combined CAGR of ...
(Date:2/2/2017)... 2017  Central to its deep commitment to ... The Japan Prize Foundation today announced the laureates ... the envelope in their respective fields of Life ... are being recognized with the 2017 Japan Prize ... contribute to the advancement of science and technology, ...
Breaking Biology News(10 mins):
(Date:2/16/2017)... 2017  ImMAGE Biotherapeutics (OTCMKTS: IMMG), an early-stage biotechnology company ... better treatment for triple negative breast cancer (TNBC), announced today ... program. The YEi Start in ... help entrepreneurs grow their business in France ... companies selected to complete an intensive one week immersion in ...
(Date:2/16/2017)... 16, 2017   Capricor Therapeutics, Inc. ... company developing first-in-class biological therapies for cardiac and ... elected to terminate its license agreement with the ... including Cenderitide. "Our decision to return ... prioritize our efforts to advance our core cell ...
(Date:2/16/2017)... N.J. , Feb. 16, 2017  Champions Oncology, ... in the development and sale of advanced technology solutions ... oncology drugs, today announced the addition of new cohorts ... These new models will expand Champions, product line ... head and neck cancer, AML, and non-small cell lung ...
(Date:2/16/2017)... ... February 16, 2017 , ... ... further extended its industry leading Biochemistry Services specifically targeting the rapidly growing ... and methods for the biochemical and biosimilar characterization , product-related impurity ...
Breaking Biology Technology:
Cached News: